CapStone Downgrades Endologix (ELGX) to Hold; Outlook May Be Marginal At Best
Tweet Send to a Friend
CapStone downgrades Endologix, Inc. (Nasdaq: ELGX) from Buy to Hold. PT $6.
CapStone analyst says, "Despite guiding to higher Y/Y ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
CapStone analyst says, "Despite guiding to higher Y/Y ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
